TY - JOUR
T1 - Experiences of women desiring pregnancy following uterine fibroid diagnosis
AU - Dsouza, Karen N.
AU - Riggan, Kirsten A.
AU - Orellana, Minerva
AU - Venable, Sateria
AU - Stewart, Elizabeth A.
AU - Balls-Berry, Joyce E.
AU - Allyse, Megan A.
N1 - Funding Information:
Megan A. Allyse is funded by the Mayo Clinic Department of Obstetrics and Gynecology and by NHGRI grant K01 HG009642. Joyce E. Balls-Berry is funded by PPRN-1501-26817, TR 02494, and HS023418. Elizabeth A. Stewart, Joyce E. Balls-Berry, and Sateria Venable report additional funding from the Agency for Healthcare Research and Quality grant P50HS023418. Joyce E. Balls- Berry reports consultation with Boston Scientific and Parabon NanoLabs, Inc. Elizabeth A. Stewart reports consulting for AbbVie, Bayer, and Myovant Consulting related to uterine fibroids and payment for development of educational content from UpToDate, Med Learning Group, and Peer View. Sateria Venable reports consulting for AbbVie, Myovant, and Bayer.
Funding Information:
This project was funded by Mayo Clinic’s Office of Health Disparities Research. The authors would like to thank the Fibroid Foundation and the women who volunteered to share their experiences with us. We also thank Anna Gilbert for her assistance with data analysis.
Funding Information:
Financial Disclosures: Megan A. Allyse is funded by the Mayo Clinic Department of Obstetrics and Gynecology and by NHGRI grant K01 HG009642. Joyce E. Balls-Berry is funded by PPRN-1501-26817, TR 02494, and HS023418. Elizabeth A. Stewart, Joyce E. Balls-Berry, and Sateria Venable report additional funding from the Agency for Healthcare Research and Quality grant P50HS023418. Joyce E. Balls-Berry reports consultation with Boston Scientific and Parabon NanoLabs, Inc. Elizabeth A. Stewart reports consulting for AbbVie, Bayer, and Myovant Consulting related to uterine fibroids and payment for development of educational content from UpToDate, Med Learning Group, and Peer View. Sateria Venable reports consulting for AbbVie, Myovant, and Bayer.
Publisher Copyright:
© Journal of Reproductive Medicine Inc.
PY - 2021/8
Y1 - 2021/8
N2 - OBJECTIVE: To investigate rationale for treatment decisions regarding reproductive planning, implications of those treatment decisions, and reproductive outcomes following uterine fibroid diagnosis. STUDY DESIGN: Qualitative research methods were used to develop a semi-structured interview guide. Telephone interviews were conducted with women of reproductive age (18–45 years) with a uterine fibroid diagnosis. Iterative themes were identified following analysis of interviews using principles of grounded theory. RESULTS: Of the 47 women who completed an interview, 40 expressed a desire for future pregnancy or had attempted to conceive following a uterine fibroid diagnosis, including 6 who had experienced or intended to undergo an assisted reproduction procedure. Many participants believed that provider discussions about the impact of uterine fibroids on fertility were intended to rule out fertility-sparing treatment options instead of supporting their reproductive goals. Reproductive outcomes varied, including live births, miscarriage, complicated pregnancies, and failure to conceive. Participants attributed negative outcomes to uterine fibroids even when unconfirmed by a medical provider and reported relational, financial, and emotional impacts of navigating reproduction following uterine fibroid diagnosis. CONCLUSION: Findings suggest that fertility options, including assisted reproduction, should be proactively discussed early in the diagnosis and treatment process.
AB - OBJECTIVE: To investigate rationale for treatment decisions regarding reproductive planning, implications of those treatment decisions, and reproductive outcomes following uterine fibroid diagnosis. STUDY DESIGN: Qualitative research methods were used to develop a semi-structured interview guide. Telephone interviews were conducted with women of reproductive age (18–45 years) with a uterine fibroid diagnosis. Iterative themes were identified following analysis of interviews using principles of grounded theory. RESULTS: Of the 47 women who completed an interview, 40 expressed a desire for future pregnancy or had attempted to conceive following a uterine fibroid diagnosis, including 6 who had experienced or intended to undergo an assisted reproduction procedure. Many participants believed that provider discussions about the impact of uterine fibroids on fertility were intended to rule out fertility-sparing treatment options instead of supporting their reproductive goals. Reproductive outcomes varied, including live births, miscarriage, complicated pregnancies, and failure to conceive. Participants attributed negative outcomes to uterine fibroids even when unconfirmed by a medical provider and reported relational, financial, and emotional impacts of navigating reproduction following uterine fibroid diagnosis. CONCLUSION: Findings suggest that fertility options, including assisted reproduction, should be proactively discussed early in the diagnosis and treatment process.
KW - Assisted reproductive technology
KW - Cost of illness
KW - Fertility preservation
KW - Infertility
KW - Patient- centered care
KW - Qualitative research
KW - Quality of life
KW - Subfertility
KW - Uterine fibroids
KW - Uterine neoplasms
UR - http://www.scopus.com/inward/record.url?scp=85120787282&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85120787282
SN - 0024-7758
VL - 66
SP - 169
EP - 175
JO - Journal of Reproductive Medicine
JF - Journal of Reproductive Medicine
IS - 7-8
ER -